Reference - Detail
| RRC ID | 57644 |
|---|---|
| Author | Nagoya T, Kamimura K, Goto R, Shinagawa-Kobayashi Y, Niwa Y, Kimura A, Sakai N, Ko M, Nishina H, Terai S. |
| Title | Inhibition of sodium-glucose cotransporter 2 ameliorates renal injury in a novel medaka model of nonalcoholic steatohepatitis-related kidney disease. |
| Journal | FEBS Open Bio |
| Abstract |
The effect of sodium-glucose cotransporter 2 inhibitor (SGLT2I) on nonalcoholic steatohepatitis (NASH) has been reported, but there are few studies on its effect on NASH-related renal injury. In this study, we examined the effect of SGLT2I using a novel medaka fish model of NASH-related kidney disease, which was developed by feeding the d-rR/Tokyo strain a high-fat diet. SGLT2I was administered by dissolving it in water of the feeding tank. SGLT2I ameliorates macrophage accumulation and oxidative stress and maintained mitochondrial function in the kidney. The results demonstrate the effect of SGLT2I on NASH-related renal injury and the usefulness of this novel animal model for research into NASH-related complications. |
| Volume | 9(12) |
| Pages | 2016-2024 |
| Published | 2019-12-1 |
| DOI | 10.1002/2211-5463.12734 |
| PMID | 31561285 |
| PMC | PMC6886305 |
| MeSH | Animals Benzhydryl Compounds / pharmacology* Diabetes Mellitus, Type 2 Diet, High-Fat Disease Models, Animal Glucose / metabolism Glucosides / pharmacology* Glutamate Plasma Membrane Transport Proteins / antagonists & inhibitors Glutamate Plasma Membrane Transport Proteins / metabolism* Glutamate Plasma Membrane Transport Proteins / physiology Hypoglycemic Agents Kidney / pathology Kidney Diseases / metabolism* Kidney Diseases / physiopathology Non-alcoholic Fatty Liver Disease / complications Non-alcoholic Fatty Liver Disease / metabolism Oryzias / metabolism Sodium / metabolism Sodium-Glucose Transporter 2 Inhibitors / pharmacology |
| IF | 2.231 |
| Times Cited | 0 |
| Resource | |
| Medaka | d-rR/TOKYO (MT837) |